Axon Enterprise (NASDAQ:AXON) Shares Gap Up – Time to Buy?

Axon Enterprise, Inc. (NASDAQ:AXON) gapped up prior to trading on Tuesday . The stock had previously closed at $636.39, but opened at $652.82. Axon Enterprise shares last traded at $648.53, with a volume of 91,247 shares.

Analysts Set New Price Targets

A number of research analysts recently commented on AXON shares. Robert W. Baird upped their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Craig Hallum increased their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, Barclays boosted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $460.33.

Axon Enterprise Stock Up 1.2 %

The business’s 50 day simple moving average is $493.10 and its 200 day simple moving average is $382.63. The company has a market capitalization of $49.10 billion, a PE ratio of 167.58, a price-to-earnings-growth ratio of 14.24 and a beta of 1.01. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 8,182 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $364.86, for a total value of $2,985,284.52. Following the transaction, the insider now owns 176,228 shares in the company, valued at approximately $64,298,548.08. This represents a 4.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the sale, the director now directly owns 3,653 shares of the company’s stock, valued at $1,291,445.09. This trade represents a 19.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 135,256 shares of company stock valued at $61,043,370 in the last three months. 5.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Axon Enterprise

Hedge funds have recently modified their holdings of the stock. CIBC Asset Management Inc lifted its holdings in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise in the third quarter worth approximately $221,000. Sequoia Financial Advisors LLC increased its stake in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares during the last quarter. Axxcess Wealth Management LLC bought a new position in shares of Axon Enterprise during the 3rd quarter valued at $814,000. Finally, Soros Capital Management LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $630,000. 79.08% of the stock is owned by institutional investors and hedge funds.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.